91
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Dermal and ocular exposure systems for the development of models of sulfur mustard-induced injury

, , , , , & show all
Pages 547-553 | Received 28 Jan 2011, Accepted 04 Mar 2011, Published online: 08 Apr 2011

References

  • Balali-Mood M, Hefazi M. 2005. The pharmacology, toxicology, and medical treatment of sulfur mustard poisoning. Fundam Clin Pharmacol 19:297–315.
  • Benson JM, March TH, Seagrave JC, Weber WM, Santistevan CD, Grotendorst GR, Schultz GS. 2010a. Time course of lesion development in the hairless guinea pig model of sulfur mustard induced dermal injury. Wound Repair Regen, in press.
  • Benson JM, Tibbetts BM, Weber WM, Grotendorst GR. 2010b. Uptake, tissue distribution, and excretion of 14C-sulfur mustard vapor following inhalation in F344 rats and cutaneous exposure in hairless guinea pigs. J Appl Toxicol, in press.
  • Colardyn F, De Bersaques J. 1984. Clinical observations and therapy of injuries with vesicants. In: Heyndrickx A, ed. Proceedings of the First World Congress on New Compounds in Biological and Chemical Warfare. Rijksuniversiteit, Ghent, Belgium, pp. 254–259.
  • Dahl H, Gluud B, Vangested P, Norn M. 1985. Eye lesions induced by mustard gas. South Med J 173:s30–s81.
  • Dalton CH, Maidment MP, Jenner J, Chilcott RP. 2006. Closed cup vapor systems in percutaneous exposure studies: what is the dose? J Anal Toxicol 30:165–170.
  • DHS (Department of Homeland Security). 2007. 6 CFR Part 27, Appendix to Chemical Facility Anti-Terrorism Standards; Final Rule (November 2007). [Online] Available at: http://www.dhs.gov/xlibrary/assets/chemsec_appendixafinalrule.pdf
  • FDA. 2008. Animal Models—Essential Elements to Address Efficacy Under the Animal Rule (September 2008). [Online] Available at: http://www.fda.gov/cder/guidance/8324concept.pdf
  • Geeraets WJ, Abedi S, Blanke RV. 1977. Acute corneal injury by mustard gas. South Med J 70:348–350.
  • Karalliedde L, Wheeler H, Maclehose R, Murray V. 2000. Possible immediate and long-term health effects following exposure to chemical warfare agents. Public Health 114:238–248.
  • Kehe K, Balszuweit F, Emmler J, Kreppel H, Jochum M, Thiermann H. 2008. Sulfur mustard research—strategies for the development of improved medical therapy. Eplasty 8:e32.
  • Lopez S, Santistevan DC, Weber W, March T, Seagrave J, Schultz G, Tuli S, Talton J, Grotendorst G. 2010. Drug efficacy evaluations for treatment of sulfur mustard ocular and dermal injury. Toxicologist 114: Abstract #351.
  • Mellor SG, Rice P, Cooper GJ. 1991. Vesicant burns. Br J Plast Surg 44:434–437.
  • Momeni AZ, Enshaeih S, Meghadi M, Amindjavaheri M. 1992. A clinical study of 535 patients exposed to mustard gas. Arch Dermatol 128:775–780.
  • Sidell FR. 1998. Chemical warfare agents. In: Viccellio P, ed. Emergency Toxicology. Lippincott-Raven Publishers, Philadelphia, PA, pp. 255–266.
  • Smith WJ, Dunn MA. 1991. Medical defense against blistering chemical warfare agents. Arch Dermatol 127:1207–1213.
  • USARMY. 2008. Nuclear and Chemical Weapons and Material. Chemical Surety. [Online] Available at: http://www.fas.org/irp/doddir/army/ar50-6.pdf
  • Weber WM, Kracko DA, Lehman MR, Irvin CM, Blair LF, White RK, Benson JM, Grotendorst GR, Cheng YS, McDonald JD. 2010. Inhalation exposure systems for the development of rodent models of sulfur mustard-induced pulmonary injury. Toxicol Mech Methods 20:14–24.
  • Willems JL. 1989. Clinical management of mustard gas casualties. Ann Med Mil Belg 3:S1–S61.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.